Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Exercise to reduce Alzheimer's risk in older African Americans

Official title: Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"

Run by Pennington Biomedical Research Center · NCT03890861 · Data updated 2026-11-12

This study is testing if a special exercise program can help older African American adults at risk for Alzheimer's improve their memory and brain health.

More Alzheimer Dementia (AD) trials

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment125 (estimated)
SponsorPennington Biomedical Research Center
Academic / other
Locations1 site (Baton Rouge, Louisiana)
StatusRecruiting
StartedAugust 9, 2019
Main results expectedNovember 2025
Study endsNovember 2026
Registry record updatedNovember 25, 2024
Trial IDNCT03890861 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are African American adults aged 60 and older who are not currently engaged in regular physical activity.

Probably not a fit

Patients with cognitive impairments that interfere with group participation or those unable to safely engage in exercise may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effects of a tailored physical activity program on cognitive function and brain health in older African American adults at risk for Alzheimer's Disease. Participants will be randomly assigned to either the physical activity intervention or an active control group. The study focuses on measuring changes in episodic memory, executive functioning, and various physiological parameters associated with Alzheimer's. By promoting regular exercise, the study seeks to address health disparities and improve cognitive outcomes in this population.

Why it matters

Potential benefit: If successful, this study could lead to effective strategies for reducing Alzheimer's Disease risk and improving cognitive health in older African Americans.

How similar studies have gone: Previous studies have shown that exercise can improve cognitive function in older adults, suggesting potential success for this tailored approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. self- identify as African American
2. 60 years and older
3. willing to accept randomization
4. willing to attend group sessions
5. lacking plans to move during the study period
6. free of conditions that would make regular exercise unsafe (e.g. uncontrolled asthma, severe sickle cell disease, etc.)
7. not engaged in regular physical activity
8. Short Physical Performance Battery score \>/= 4
9. physically capable of exercise,

Exclusion Criteria:

1. cognitive impairment that would interfere with participating in group interactions
2. unwilling to give written informed consent
3. inability to attend group sessions
4. conditions that prevent regular exercise
5. conditions that the medical or principal investigator determine to warrant exclusion

Where it's running

  • Pennington Biomedical Research Center
    Baton Rouge, Louisiana, United States
    Recruiting

Study contacts

  • Principal investigator: Robert L Newton, Jr., PhD — Pennington Biomedical Research Center
  • Study coordinator: Melissa Harris, PhD
  • Email: Melissa.Harris@pbrc.edu
  • Phone: 225763091

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Creating a Korean cohort to track cognitive aging

    This project will use smartphone surveys, a wearable watch, and blood tests to see if daily emotional stress is linked to short- and long-term thinking problems and inflammation in adults 60 and older in Seoul.

    Recruiting Korea University · Seoul, Select One... · NCT07485387

  • Amyloid deposits in the heart and heart function in people with Alzheimer's disease

    This project will see if the same amyloid buildup found in Alzheimer's also shows up in the heart by adding a heart amyloid PET/MRI, an echocardiogram, and a dementia exam for people already having a brain amyloid PET.

    Recruiting University Hospital, Essen · Essen, North Rhine-Westphalia · NCT07154394

  • RICORDO digital cognitive rehabilitation program for older adults

    This project will test whether the RICORDO digital rehabilitation program can help people aged 65 and older with subjective memory complaints, mild cognitive impairment, or mild Alzheimer's dementia improve thinking skills and better manage their own health.

    Recruiting Fondazione Don Carlo Gnocchi ETS · Milan · NCT07064226

  • Cervical lymphatic bypass for treating Alzheimer's disease

    This study is testing a new surgery to see if it can help people with mild to moderate Alzheimer's disease by improving the way the brain clears out harmful proteins.

    Recruiting Changi General Hospital · Singapore · NCT06965062

  • Testing rifaximin for improving gut health in dementia patients

    This study is testing if a new form of rifaximin can improve gut health and help people with Alzheimer's and Vascular Dementia feel better and function more effectively.

    Recruiting Phase 1/2 Hunter Holmes Mcguire Veteran Affairs Medical Center · Richmond, Virginia · NCT06718686

  • Measuring eye changes to detect dementia

    This study is testing a new eye exam to see if it can help tell the difference between people with and without dementia.

    Recruiting MD Stem Cells · Coconut Creek, Florida · NCT06613971

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.